Rockefeller Capital Management L.P. Intellia Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

$42.4 Billion
Q2 2025

A detailed history of Rockefeller Capital Management L.P. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 137,838 shares of NTLA stock, worth $3.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

137,838

Previous 137,838 -0.0%

Holding current value

$3.38 Million

Previous $1.29 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$11.41 - $21.09 $705,138 - $1.3 Million	61,800 Added 81.28%	137,838 $1.61 Million
Q3 2024 Nov 14, 2024	SELL	$19.72 - $27.36 $490,554 - $680,607	-24,876 Reduced 24.65%	76,038 $1.56 Million
Q2 2024 Aug 12, 2024	BUY	$20.02 - $27.22 $491,871 - $668,768	24,569 Added 32.18%	100,914 $2.26 Million
Q1 2024 May 14, 2024	BUY	$23.82 - $32.8 $473,208 - $651,604	19,866 Added 35.17%	76,345 $2.1 Million
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $230,858 - $322,365	9,968 Added 21.43%	56,479 $1.72 Million
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $305,385 - $442,143	9,658 Added 26.21%	46,511 $1.47 Million
Q2 2023 Aug 14, 2023	BUY	$34.58 - $46.03 $162,664 - $216,525	4,704 Added 14.63%	36,853 $1.5 Million
Q1 2023 May 17, 2023	BUY	$33.3 - $44.82 $292,640 - $393,878	8,788 Added 37.62%	32,149 $1.2 Million
Q4 2022 Mar 06, 2023	SELL	$33.21 - $62.69 $236,754 - $446,917	-7,129 Reduced 23.38%	23,361 $815,000
Q3 2022 Nov 02, 2022	BUY	$53.92 - $71.7 $429,095 - $570,588	7,958 Added 35.32%	30,490 $1.71 Million
Q2 2022 Aug 12, 2022	BUY	$38.49 - $76.21 $24,710 - $48,926	642 Added 2.93%	22,532 $1.17 Million
Q1 2022 May 13, 2022	BUY	$58.27 - $118.99 $397,051 - $810,797	6,814 Added 45.2%	21,890 $1.59 Million
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $1.18 Million - $1.61 Million	11,669 Added 342.5%	15,076 $1.78 Million
Q3 2021 Nov 12, 2021	BUY	$132.37 - $176.78 $360,972 - $482,079	2,727 Added 401.03%	3,407 $457,000
Q2 2021 Aug 10, 2021	BUY	$60.88 - $161.91 $3,287 - $8,743	54 Added 8.63%	680 $109,000
Q1 2021 May 11, 2021	BUY	$46.59 - $83.68 $11,787 - $21,171	253 Added 67.83%	626 $50,000
Q4 2020 Feb 12, 2021	BUY	$18.83 - $63.53 $903 - $3,049	48 Added 14.77%	373 $20,000
Q3 2020 Nov 13, 2020	BUY	$17.47 - $24.93 $5,677 - $8,102	325 New	325 $6,000
Q1 2020 May 12, 2020	SELL	$9.44 - $15.58 $66 - $109	-7 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$10.43 - $17.67 $73 - $123	7 New	7 $0

Others Institutions Holding NTLA

# of Institutions

334

Shares Held

97.1M

Call Options Held

1.66M

Put Options Held

1.03M

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.86B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account

Rockefeller Capital Management L.P. Intellia Therapeutics, Inc. Transaction History